The store will not work correctly when cookies are disabled.
(R*)-4-((S*)-5-Methoxy-1-oxo-2,3-dihydro-1H-inden-2-yl)-3-methylenechroman-2-one
ID: ALA4090342
PubChem CID: 137643539
Max Phase: Preclinical
Molecular Formula: C20H16O4
Molecular Weight: 320.34
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: C=C1C(=O)Oc2ccccc2[C@H]1[C@@H]1Cc2cc(OC)ccc2C1=O
Standard InChI: InChI=1S/C20H16O4/c1-11-18(15-5-3-4-6-17(15)24-20(11)22)16-10-12-9-13(23-2)7-8-14(12)19(16)21/h3-9,16,18H,1,10H2,2H3/t16-,18-/m0/s1
Standard InChI Key: NNAMHCWHJLNIIH-WMZOPIPTSA-N
Molfile:
RDKit 2D
26 29 0 0 0 0 0 0 0 0999 V2000
13.7983 -9.1922 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.2163 -8.6103 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4246 -9.9255 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6232 -7.7929 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0352 -7.0866 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8545 -7.0902 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.2601 -7.8059 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8416 -8.5070 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0307 -8.5040 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6203 -9.2008 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0254 -9.9052 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8363 -9.9083 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.2422 -9.2069 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.2432 -10.6170 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.6149 -10.6118 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.2059 -8.4897 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
14.2059 -9.9012 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
13.3442 -7.8032 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.6117 -9.7968 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.4838 -8.9845 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7178 -8.6907 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0790 -9.2082 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.2114 -10.0230 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9774 -10.3130 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5785 -10.5400 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.8143 -10.2504 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 20 1 0
19 3 1 0
3 1 1 0
4 5 1 0
5 6 2 0
6 7 1 0
7 8 2 0
9 8 1 0
9 4 2 0
10 9 1 0
11 10 1 0
12 11 1 0
13 12 1 0
8 13 1 0
12 14 2 0
11 15 2 0
10 1 1 0
10 16 1 1
1 17 1 1
2 18 2 0
19 20 2 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 19 1 0
23 25 1 0
25 26 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 320.34 | Molecular Weight (Monoisotopic): 320.1049 | AlogP: 3.31 | #Rotatable Bonds: 2 |
Polar Surface Area: 52.60 | Molecular Species: NEUTRAL | HBA: 4 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 3.73 | CX LogD: 3.73 |
Aromatic Rings: 2 | Heavy Atoms: 24 | QED Weighted: 0.48 | Np Likeness Score: 0.82 |